141 related articles for article (PubMed ID: 25799875)
1. [Health-related quality of life in phase III cancer clinical trials: from questionnaire administration to statistical analysis].
Fiteni F; Anota A; Westeel V; Bonnetain F
Bull Cancer; 2015 Apr; 102(4):360-6. PubMed ID: 25799875
[TBL] [Abstract][Full Text] [Related]
2. Methodology of health-related quality of life analysis in phase III advanced non-small-cell lung cancer clinical trials: a critical review.
Fiteni F; Anota A; Westeel V; Bonnetain F
BMC Cancer; 2016 Feb; 16():122. PubMed ID: 26892541
[TBL] [Abstract][Full Text] [Related]
3. Endpoints in cancer clinical trials.
Fiteni F; Westeel V; Pivot X; Borg C; Vernerey D; Bonnetain F
J Visc Surg; 2014 Feb; 151(1):17-22. PubMed ID: 24440056
[TBL] [Abstract][Full Text] [Related]
4. Added value of health-related quality of life measurement in cancer clinical trials: the experience of the NCIC CTG.
Au HJ; Ringash J; Brundage M; Palmer M; Richardson H; Meyer RM;
Expert Rev Pharmacoecon Outcomes Res; 2010 Apr; 10(2):119-28. PubMed ID: 20384559
[TBL] [Abstract][Full Text] [Related]
5. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
6. Health-related quality-of-life as co-primary endpoint in randomized clinical trials in oncology.
Fiteni F; Pam A; Anota A; Vernerey D; Paget-Bailly S; Westeel V; Bonnetain F
Expert Rev Anticancer Ther; 2015; 15(8):885-91. PubMed ID: 26027598
[TBL] [Abstract][Full Text] [Related]
7. [Health related quality of life and endpoints in oncology].
Bonnetain F
Cancer Radiother; 2010 Oct; 14(6-7):515-8. PubMed ID: 20674446
[TBL] [Abstract][Full Text] [Related]
8. Health-related quality of life assessment in contemporary phase III trials in advanced colorectal cancer.
Adamowicz K; Saad ED; Jassem J
Cancer Treat Rev; 2016 Nov; 50():194-199. PubMed ID: 27718458
[TBL] [Abstract][Full Text] [Related]
9. Health-related quality of life as an endpoint in oncology phase I trials: a systematic review.
Fiteni F; Ray IL; Ousmen A; Isambert N; Anota A; Bonnetain F
BMC Cancer; 2019 Apr; 19(1):361. PubMed ID: 30991990
[TBL] [Abstract][Full Text] [Related]
10. Social determinants of health-related quality of life.
Kivits J; Erpelding ML; Guillemin F
Rev Epidemiol Sante Publique; 2013 Aug; 61 Suppl 3():S189-94. PubMed ID: 23849946
[TBL] [Abstract][Full Text] [Related]
11. Assessment of quality of life in advanced non-small-cell lung cancer: an overview of recent randomized trials.
Saad ED; Adamowicz K; Katz A; Jassem J
Cancer Treat Rev; 2012 Oct; 38(6):807-14. PubMed ID: 22445316
[TBL] [Abstract][Full Text] [Related]
12. Item response models for the longitudinal analysis of health-related quality of life in cancer clinical trials.
Barbieri A; Peyhardi J; Conroy T; Gourgou S; Lavergne C; Mollevi C
BMC Med Res Methodol; 2017 Sep; 17(1):148. PubMed ID: 28950850
[TBL] [Abstract][Full Text] [Related]
13. Assessment of quality of life in phase III trials of radiotherapy in localized or locally advanced head and neck cancer over the past 17 years.
Marta GN; Saad ED
Ann Palliat Med; 2017 Jan; 6(1):73-80. PubMed ID: 28209070
[TBL] [Abstract][Full Text] [Related]
14. Comparison of three longitudinal analysis models for the health-related quality of life in oncology: a simulation study.
Anota A; Barbieri A; Savina M; Pam A; Gourgou-Bourgade S; Bonnetain F; Bascoul-Mollevi C
Health Qual Life Outcomes; 2014 Dec; 12():192. PubMed ID: 25551580
[TBL] [Abstract][Full Text] [Related]
15. Health related quality of life outcomes in cancer clinical trials.
Bottomley A; Flechtner H; Efficace F; Vanvoorden V; Coens C; Therasse P; Velikova G; Blazeby J; Greimel E;
Eur J Cancer; 2005 Aug; 41(12):1697-709. PubMed ID: 16043345
[TBL] [Abstract][Full Text] [Related]
16. Other paradigms: health-related quality of life as a measure in cancer treatment: its importance and relevance.
Trask PC; Hsu MA; McQuellon R
Cancer J; 2009; 15(5):435-40. PubMed ID: 19826365
[TBL] [Abstract][Full Text] [Related]
17. Health-related quality of life and psychological distress during neoadjuvant endocrine therapy with letrozole to determine endocrine responsiveness in postmenopausal breast cancer.
Taira N; Iwata H; Hasegawa Y; Sakai T; Higaki K; Kihara K; Yamaguchi T; Ohsumi S; Shimozuma K; Ohashi Y
Breast Cancer Res Treat; 2014 May; 145(1):155-64. PubMed ID: 24692082
[TBL] [Abstract][Full Text] [Related]
18. Beyond the development of health-related quality-of-life (HRQOL) measures: a checklist for evaluating HRQOL outcomes in cancer clinical trials--does HRQOL evaluation in prostate cancer research inform clinical decision making?
Efficace F; Bottomley A; Osoba D; Gotay C; Flechtner H; D'haese S; Zurlo A
J Clin Oncol; 2003 Sep; 21(18):3502-11. PubMed ID: 12972527
[TBL] [Abstract][Full Text] [Related]
19. Adolescents' psychosocial health-related quality of life within 6 months after cancer treatment completion.
Ruccione K; Lu Y; Meeske K
Cancer Nurs; 2013; 36(5):E61-72. PubMed ID: 23632469
[TBL] [Abstract][Full Text] [Related]
20. Evaluating health-related quality of life in cancer clinical trials: the National Cancer Institute of Canada Clinical Trials Group experience.
Osoba D; Bezjak A; Brundage M; Pater J;
Value Health; 2007; 10 Suppl 2():S138-45. PubMed ID: 17995472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
